S H Kelkar and Company Limited

SHK

INE500L01026

Specialty Chemicals

Delayed NSE India S.E. Other stock markets 12:24:40 16/06/2025 pm IST			5-day change	1st Jan Change
242.95 ^INR	+1.85%		-1.72%	-1.50%

26/05	S H Kelkar and Company Limited, Q4 2025 Earnings Call, May 22, 2025
19/05	S H Kelkar Gets Board Nod to Form New Wholly-Owned Subsidiary in UAE	MT

SH Kelkar Invests Additional 5 Million Euros in Wholly-Owned Subsidiary

Published on 26/10/2023 at 10:57, updated on 26/10/2023 at 10:58

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about S H Kelkar and Company Limited

S H Kelkar and Company Limited, Q4 2025 Earnings Call, May 22, 2025	26/05
S H Kelkar Gets Board Nod to Form New Wholly-Owned Subsidiary in UAE	19/05	MT
S H Kelkar and Company Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	16/05	CI
S H Kelkar and Company Limited Appoints Pallavi Gokhale as an Additional Director (Non-Executive Non-Independent), Effective July 1, 2025	16/05	CI
S H Kelkar and Company Limited Approves Incorporation of Wholly Owned Subsidiary by Name Keva Middle East FZE	16/05	CI
S H Kelkar And Company March-Qtr Consol Net Profit 1.03 Bln Rupees	16/05	RE
S H Kelkar and Company Limited Approves Company Secretary and Compliance Officer Changes	30/04	CI
S H Kelkar and Company Limited Announces Executive Appointments	11/04	CI
S H Kelkar And Company Says Consolidated Revenues For Fy2025 Up 15% YoY	03/04	RE
S H Kelkar and Company Limited, Q3 2025 Earnings Call, Feb 17, 2025	17/02
S H Kelkar and Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	12/02	CI
S H Kelkar and Company Limited Announces the Cessation of Mr. Mark Elliott as an Independent Director of the Company	14/12	CI
S H Kelkar and Company Limited Provides Revenue Guidance for the Second Half and Full Year of 2024	18/11	CI
S H Kelkar and Company Limited, Q2 2025 Earnings Call, Nov 18, 2024	18/11
S H Kelkar and Company Limited Announces Unaudited Consolidated Revenue Results for the First Half of 2025	04/24/04	CI
S H Kelkar and Company Limited, Q1 2025 Earnings Call, Aug 14, 2024	14/24/14
S H Kelkar and Company Limited Approves Capacity Addition	13/24/13	CI
S H Kelkar and Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	13/24/13	CI
Keva Middle East FZE announced that it expects to receive AED 0.1 million in funding from S H Kelkar and Company Limited	13/24/13	CI
Keva Europe B.V. announced that it expects to receive ?18 million in funding from S H Kelkar and Company Limited	13/24/13	CI
Keva USA announced that it expects to receive $1.99 million in funding from S H Kelkar and Company Limited	13/24/13	CI
S H Kelkar and Company Limited Reports Unaudited Consolidated Sales Results for the First Quarter of Fiscal Year 2025	01/24/01	CI
S H Kelkar And Company Forms Step-Down Subsidiary in Germany	05/24/05	MT
S H Kelkar and Company Limited, Q4 2024 Earnings Call, May 28, 2024	28/24/28
S H Kelkar and Company Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/24/27	CI

Chart S H Kelkar and Company Limited

Duration

Period

SHK: Dynamic Chart

S H Kelkar and Company Limited is an India-based fragrance and flavour company. The Company is engaged in the business of manufacturing, supplying and exporting fragrances, flavours and aroma ingredients. The Company's segments include Fragrance and Flavours. The fragrance segment includes fragrance products that are used by various consumption categories, such as personal wash, soaps and detergents, sanitizers, home cleaners, fabric care and fine fragrances, among others. Flavours segment includes flavour products that are used as raw material by producers of baked goods, dairy products, beverages and pharmaceutical products. Its natural actives product portfolio includes Camisooth, AloeHeal, Glycibright, OleoKare, and Puniblock. It offers products under SHK, Cobra, Auris, Wheel, Three Birds, and Keva brands. It provides a range of research and testing services in the areas of biotechnology and microbiology research, cosmetic research, cosmetic biotechnology, and custom synthesis.

Employees

603

Sector

Specialty Chemicals

Calendar

12/08 - Annual General Meeting

More about the company